2026 Global: Bovine Tubercolosis Diagnosis-Competitive Review (2032) report
Description
The 2026 Global: Bovine Tubercolosis Diagnosis-Competitive Review (2031) report features the global market size and projected growth/decline data for the period 2021 through 2032. The report primarily provides an examination of the business strategies for the ten largest global companies in the market and how their strategies differ.
Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2021 to 2032 using regression analysis in our modeling. and Perry/Hope is the only market research publisher that utilizes both longitudinal (historical) and vertical (from market section to market division to market class) analysis, since we study every manufactured product in the countries we analyze. The report also provides written analysis on the market definition, market segments, and SWOT analysis (market strengths, weaknesses, opportunities, and threats).
The market study aims at estimating the market size and the growth potential of this market. Topics analyzed within the report include a detailed breakdown of the global markets for bovine tubercolosis diagnosis by geography and historical trend. The scope of the report extends to sizing of the bovine tubercolosis diagnosis market and global market trends with market data for 2024 as the base year, 2025 and 2026 as the estimate years with projection of CAGR from 2027 to 2032.
The report also features a list of the top ten largest global players in the market. A review of each company includes 1) an estimate of the market share, 2) a listing of the products and/or services in the market, and 3) the features of these products and/or services in the market. The report has a chapter on Comparative Business Strategies for the largest four players. An example of the Comparative Business Strategies analysis would be -- How does Netflix's business strategy to expand its market share in the global online streaming compare to Amazon Prime's business strategy through its video products and services?
The ten market players in this report and a brief synopsis of their participation in the market are:
Bio-Rad Laboratories, IDEXX Laboratories, IDvet (Innovative Diagnostics SAS), Thermo Fisher Scientific, Zoetis, PBD Biotech, Enfer Group, LIONEX, Chembio Diagnostics, and QIAGEN are widely cited among the leading companies providing bovine tuberculosis (bTB) diagnostic solutions, offering combinations of skin-test reagents, serological ELISAs, interferon-gamma assays, molecular PCR platforms, and supporting laboratory services tailored for livestock disease surveillance and control. Bio-Rad and IDEXX are noted for veterinary diagnostics portfolios and validated immunoassays used in bTB testing programs. IDvet specializes in animal health ELISA kits including tests for bovine tuberculosis and supplies reagents used in national surveillance efforts. Thermo Fisher and QIAGEN supply molecular platforms and nucleic acid amplification tests that enable laboratory confirmation of Mycobacterium bovis infection and integration with high-throughput workflows. Zoetis combines veterinary-focused diagnostics, vaccines and herd-health services that support diagnostics-driven control strategies in production systems.
PBD Biotech, Enfer Group and LIONEX are recognized for niche and regionally adopted diagnostic assays and technologies that address specific gaps in bTB detection and differentiation, including rapid immunoassays and laboratory consumables used by veterinary diagnostic networks. PBD Biotech develops assays for animal disease detection used in field and laboratory contexts, while Enfer Group offers veterinary diagnostic reagents and service support for herd health monitoring programs. LIONEX contributes molecular and serological tools targeting mycobacterial infections in animals, often used in specialized reference laboratories. Chembio Diagnostics and similar point-of-care diagnostics companies provide lateral-flow and portable testing solutions that can accelerate screening in resource-limited or on-farm settings, complementing centralized laboratory testing pathways.
Market reports and industry analyses consistently list these firms among the top players shaping the bovine tuberculosis diagnostics landscape due to their validated test portfolios, global distribution channels, regulatory clearances, and collaborations with veterinary authorities and surveillance programs. Their combined offerings span primary screening (skin tests and ELISAs), ancillary blood-based interferon-gamma assays, confirmatory culture and PCR methods, and data-supporting services that facilitate test deployment at scale and integration with national eradication programs. Regional leadership varies by technology and country, with some companies dominant in ELISA and serology, others in molecular confirmation and laboratory automation, and several positioning integrated veterinary solutions that link diagnostics with herd-health management and vaccine development.
Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2021 to 2032 using regression analysis in our modeling. and Perry/Hope is the only market research publisher that utilizes both longitudinal (historical) and vertical (from market section to market division to market class) analysis, since we study every manufactured product in the countries we analyze. The report also provides written analysis on the market definition, market segments, and SWOT analysis (market strengths, weaknesses, opportunities, and threats).
The market study aims at estimating the market size and the growth potential of this market. Topics analyzed within the report include a detailed breakdown of the global markets for bovine tubercolosis diagnosis by geography and historical trend. The scope of the report extends to sizing of the bovine tubercolosis diagnosis market and global market trends with market data for 2024 as the base year, 2025 and 2026 as the estimate years with projection of CAGR from 2027 to 2032.
The report also features a list of the top ten largest global players in the market. A review of each company includes 1) an estimate of the market share, 2) a listing of the products and/or services in the market, and 3) the features of these products and/or services in the market. The report has a chapter on Comparative Business Strategies for the largest four players. An example of the Comparative Business Strategies analysis would be -- How does Netflix's business strategy to expand its market share in the global online streaming compare to Amazon Prime's business strategy through its video products and services?
The ten market players in this report and a brief synopsis of their participation in the market are:
Bio-Rad Laboratories, IDEXX Laboratories, IDvet (Innovative Diagnostics SAS), Thermo Fisher Scientific, Zoetis, PBD Biotech, Enfer Group, LIONEX, Chembio Diagnostics, and QIAGEN are widely cited among the leading companies providing bovine tuberculosis (bTB) diagnostic solutions, offering combinations of skin-test reagents, serological ELISAs, interferon-gamma assays, molecular PCR platforms, and supporting laboratory services tailored for livestock disease surveillance and control. Bio-Rad and IDEXX are noted for veterinary diagnostics portfolios and validated immunoassays used in bTB testing programs. IDvet specializes in animal health ELISA kits including tests for bovine tuberculosis and supplies reagents used in national surveillance efforts. Thermo Fisher and QIAGEN supply molecular platforms and nucleic acid amplification tests that enable laboratory confirmation of Mycobacterium bovis infection and integration with high-throughput workflows. Zoetis combines veterinary-focused diagnostics, vaccines and herd-health services that support diagnostics-driven control strategies in production systems.
PBD Biotech, Enfer Group and LIONEX are recognized for niche and regionally adopted diagnostic assays and technologies that address specific gaps in bTB detection and differentiation, including rapid immunoassays and laboratory consumables used by veterinary diagnostic networks. PBD Biotech develops assays for animal disease detection used in field and laboratory contexts, while Enfer Group offers veterinary diagnostic reagents and service support for herd health monitoring programs. LIONEX contributes molecular and serological tools targeting mycobacterial infections in animals, often used in specialized reference laboratories. Chembio Diagnostics and similar point-of-care diagnostics companies provide lateral-flow and portable testing solutions that can accelerate screening in resource-limited or on-farm settings, complementing centralized laboratory testing pathways.
Market reports and industry analyses consistently list these firms among the top players shaping the bovine tuberculosis diagnostics landscape due to their validated test portfolios, global distribution channels, regulatory clearances, and collaborations with veterinary authorities and surveillance programs. Their combined offerings span primary screening (skin tests and ELISAs), ancillary blood-based interferon-gamma assays, confirmatory culture and PCR methods, and data-supporting services that facilitate test deployment at scale and integration with national eradication programs. Regional leadership varies by technology and country, with some companies dominant in ELISA and serology, others in molecular confirmation and laboratory automation, and several positioning integrated veterinary solutions that link diagnostics with herd-health management and vaccine development.
Table of Contents
32 Pages
- 1.0 Scope of Report and Methodology
- 2.0 Market SWOT Analysis and Players
- 2.1 Market Definition
- 2.2 Market Segments
- 2.3 Market Strengths
- 2.4 Market Weaknesses
- 2.5 Market Threats
- 2.6 Market Opportunities
- 2.7 Major Players
- 3.0 Competitive Analysis
- 3.1 Market Player 1
- 3.2 Market Player 2
- 3.3 Market Player 3
- 3.4 Market Player 4
- 3.5 Market Player 5
- 3.6 Market Player 6
- 3.7 Market Player 7
- 3.8 Market Player 8
- 3.9 Market Player 9
- 3.10 Market Player 10
- 4.0 Comparative Business Strategies
- 4.1 Comparative Business Strategies of Player 1 and 2
- 4.2 Comparative Business Strategies of Player 1 and 3
- 4.3 Comparative Business Strategies of Player 1 and 4
- 4.4 Comparative Business Strategies of Player 2 and 3
- 4.5 Comparative Business Strategies of Player 2 and 4
- 4.6 Comparative Business Strategies of Player 3 and 4
- 5.0 Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
